(1R,6R,8R,9R,10S,15R,17R,18R)-17-[6-amino-2-(2-aminoethylamino)purin-9-yl]-12-hydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-8-(3,5,7,9-tetrazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-3-yl)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol

C26H35N11O10P2S2 — CID 156899858

IUPAC(1R,6R,8R,9R,10S,15R,17R,18R)-17-[6-amino-2-(2-aminoethylamino)purin-9-yl]-12-hydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-8-(3,5,7,9-tetrazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-3-yl)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol
SMILESNCCNc1nc(N)c2ncn([C@@H]3O[C@@H]4COP(O)(=S)O[C@H]5[C@@H](O)[C@H](n6cc7c8c(ncnc86)NCCC7)O[C@@H]5COP(=O)(S)O[C@@H]3[C@@H]4O)c2n1
InChIInChI=1S/C26H35N11O10P2S2/c27-3-5-30-26-34-20(28)15-23(35-26)37(10-33-15)25-19-16(38)12(44-25)7-42-48(40,50)46-18-13(8-43-49(41,51)47-19)45-24(17(18)39)36-6-11-2-1-4-29-21-14(11)22(36)32-9-31-21/h6,9-10,12-13,16-19,24-25,38-39H,1-5,7-8,27H2,(H,40,50)(H,41,51)(H,29,31,32)(H3,28,30,34,35)/t12-,13-,16-,17-,18-,19-,24-,25-,48?,49?/m1/s1
InChIKeyOAEUTORNIZWVNC-UIHQLEEOSA-N
MW787.71 g/mol
LogP0.17
Rot. Bonds5

About (1R,6R,8R,9R,10S,15R,17R,18R)-17-[6-amino-2-(2-aminoethylamino)purin-9-yl]-12-hydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-8-(3,5,7,9-tetrazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-3-yl)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol

(1R,6R,8R,9R,10S,15R,17R,18R)-17-[6-amino-2-(2-aminoethylamino)purin-9-yl]-12-hydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-8-(3,5,7,9-tetrazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-3-yl)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol (PubChem CID 156899858) has the molecular formula C26H35N11O10P2S2 and a molecular weight of 787.71 g/mol. Its IUPAC name is (1R,6R,8R,9R,10S,15R,17R,18R)-17-[6-amino-2-(2-aminoethylamino)purin-9-yl]-12-hydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-8-(3,5,7,9-tetrazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-3-yl)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol.

Molecular Properties

Compound Name(1R,6R,8R,9R,10S,15R,17R,18R)-17-[6-amino-2-(2-aminoethylamino)purin-9-yl]-12-hydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-8-(3,5,7,9-tetrazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-3-yl)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol
PubChem CID156899858
Molecular FormulaC26H35N11O10P2S2
Molecular Weight787.71 g/mol
Exact Mass787.15
IUPAC Name(1R,6R,8R,9R,10S,15R,17R,18R)-17-[6-amino-2-(2-aminoethylamino)purin-9-yl]-12-hydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-8-(3,5,7,9-tetrazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-3-yl)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol
SMILESNCCNc1nc(N)c2ncn([C@@H]3O[C@@H]4COP(O)(=S)O[C@H]5[C@@H](O)[C@H](n6cc7c8c(ncnc86)NCCC7)O[C@@H]5COP(=O)(S)O[C@@H]3[C@@H]4O)c2n1
InChIInChI=1S/C26H35N11O10P2S2/c27-3-5-30-26-34-20(28)15-23(35-26)37(10-33-15)25-19-16(38)12(44-25)7-42-48(40,50)46-18-13(8-43-49(41,51)47-19)45-24(17(18)39)36-6-11-2-1-4-29-21-14(11)22(36)32-9-31-21/h6,9-10,12-13,16-19,24-25,38-39H,1-5,7-8,27H2,(H,40,50)(H,41,51)(H,29,31,32)(H3,28,30,34,35)/t12-,13-,16-,17-,18-,19-,24-,25-,48?,49?/m1/s1
InChIKeyOAEUTORNIZWVNC-UIHQLEEOSA-N
XLogP0.17
TPSA283.55 Ų
H-Bond Donors8
H-Bond Acceptors21
Rotatable Bonds5
Heavy Atoms51
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500787.71
LogP ≤ 50.17
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'thiol_2', 'substructure': 'N/A'}

Analyze (1R,6R,8R,9R,10S,15R,17R,18R)-17-[6-amino-2-(2-aminoethylamino)purin-9-yl]-12-hydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-8-(3,5,7,9-tetrazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-3-yl)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,6R,8R,9R,10S,15R,17R,18R)-17-[6-amino-2-(2-aminoethylamino)purin-9-yl]-12-hydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-8-(3,5,7,9-tetrazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-3-yl)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol?
The IUPAC name of (1R,6R,8R,9R,10S,15R,17R,18R)-17-[6-amino-2-(2-aminoethylamino)purin-9-yl]-12-hydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-8-(3,5,7,9-tetrazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-3-yl)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol (CID 156899858) is (1R,6R,8R,9R,10S,15R,17R,18R)-17-[6-amino-2-(2-aminoethylamino)purin-9-yl]-12-hydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-8-(3,5,7,9-tetrazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-3-yl)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol.
What is the SMILES notation for (1R,6R,8R,9R,10S,15R,17R,18R)-17-[6-amino-2-(2-aminoethylamino)purin-9-yl]-12-hydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-8-(3,5,7,9-tetrazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-3-yl)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol?
The canonical SMILES for (1R,6R,8R,9R,10S,15R,17R,18R)-17-[6-amino-2-(2-aminoethylamino)purin-9-yl]-12-hydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-8-(3,5,7,9-tetrazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-3-yl)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol is NCCNc1nc(N)c2ncn([C@@H]3O[C@@H]4COP(O)(=S)O[C@H]5[C@@H](O)[C@H](n6cc7c8c(ncnc86)NCCC7)O[C@@H]5COP(=O)(S)O[C@@H]3[C@@H]4O)c2n1.
What is the InChIKey of (1R,6R,8R,9R,10S,15R,17R,18R)-17-[6-amino-2-(2-aminoethylamino)purin-9-yl]-12-hydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-8-(3,5,7,9-tetrazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-3-yl)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol?
The InChIKey is OAEUTORNIZWVNC-UIHQLEEOSA-N. The full InChI is InChI=1S/C26H35N11O10P2S2/c27-3-5-30-26-34-20(28)15-23(35-26)37(10-33-15)25-19-16(38)12(44-25)7-42-48(40,50)46-18-13(8-43-49(41,51)47-19)45-24(17(18)39)36-6-11-2-1-4-29-21-14(11)22(36)32-9-31-21/h6,9-10,12-13,16-19,24-25,38-39H,1-5,7-8,27H2,(H,40,50)(H,41,51)(H,29,31,32)(H3,28,30,34,35)/t12-,13-,16-,17-,18-,19-,24-,25-,48?,49?/m1/s1.
What are the key properties of (1R,6R,8R,9R,10S,15R,17R,18R)-17-[6-amino-2-(2-aminoethylamino)purin-9-yl]-12-hydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-8-(3,5,7,9-tetrazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-3-yl)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol?
(1R,6R,8R,9R,10S,15R,17R,18R)-17-[6-amino-2-(2-aminoethylamino)purin-9-yl]-12-hydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-8-(3,5,7,9-tetrazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-3-yl)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol has a molecular weight of 787.71 g/mol, XLogP of 0.17, 5 rotatable bonds, 8 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,6R,8R,9R,10S,15R,17R,18R)-17-[6-amino-2-(2-aminoethylamino)purin-9-yl]-12-hydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-8-(3,5,7,9-tetrazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-3-yl)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol is sourced from PubChem (CID 156899858), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).